A genetics report for a patient with bipolar disorder shows lamotrigine (Lamictal) should be an effective treatment for them. The PMHNP will slowly titrate the dose of lamotrigine for which of the following reasons?

Choice A reason: Extrapyramidal symptoms are associated with dopamine antagonists, such as antipsychotics, and are not a concern with lamotrigine. Choice B reason: Stevens-Johnson syndrome is a rare but serious dermatologic reaction associated with lamotrigine, especially when titrated too quickly. Slow titration reduces the risk of this potentially life-threatening condition. Choice C reason: Neuroleptic malignant syndrome is linked to antipsychotic use and is not associated with lamotrigine. Choice D reason: Orthostatic hypotension is a side effect of some psychotropic medications but is not a primary concern with lamotrigine.